NewsBenzingaCanaccord Genuity avvia la copertura su Tonix Pharmaceuticals con rating Buy, annuncia un prezzo obiettivo di 18 dollari Canaccord Genuity avvia la copertura su Tonix Pharmaceuticals con rating Buy, annuncia un prezzo obiettivo di 18 dollari Benzinga 2026.10.26 12:18 (GMT+0) Open on Benzinga Other news How Tokenized Nvidia Traded Through Two Weeks of Huang Headlines What Are Wall Street Analysts' Target Price for Lumentum Holdings Stock? Texas Pacific Land Stock: Analyst Estimates & Ratings Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66